Management of histologic LSIL (CIN 1) preceded by ASC-H cytology

This algorithm describes management of histologic LSIL (CIN 1) preceded by ASC-H cytology.

LSIL: low-grade squamous intraepithelial lesion; CIN: cervical intraepithelial neoplasia; ASC-H: atypical squamous cells cannot exclude HSIL; HPV: human papillomavirus; HSIL: high-grade squamous intraepithelial lesion; ASCCP: American Society for Colposcopy and Cervical Pathology.
* Only if colposcopy visualizes the entire squamocolumnar junction and upper limit of lesion(s), and endocervical sampling negative.
¶ Except in pregnant women.

From: Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020; 24:102. DOI: 10.1097/LGT.0000000000000525. Copyright © 2020 the American Society for Colposcopy and Cervical Pathology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.

Graphic 127910 Version 3.0

خرید پکیج

Management of histologic LSIL (CIN 1) preceded by ASC-H cytology